Sonnet BioTherapeutics (SONN) Short Interest Ratio & Short Volume $3.40 -0.16 (-4.37%) As of 02:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sonnet BioTherapeutics Short Interest DataSonnet BioTherapeutics (SONN) has a short interest of 1.03 million shares, representing 18.04% of the float (the number of shares available for trading by the public). This marks a -9.65% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 1.59 million shares to cover all short positions.Current Short Interest1,030,000 sharesPrevious Short Interest1,140,000 sharesChange Vs. Previous Month-9.65%Dollar Volume Sold Short$3.42 millionShort Interest Ratio0.3 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares6,750,000 sharesFloat Size5,710,000 sharesShort Percent of Float18.04%Today's Trading Volume192,830 sharesAverage Trading Volume1,591,893 sharesToday's Volume Vs. Average12% Short Selling Sonnet BioTherapeutics? Sign up to receive the latest short interest report for Sonnet BioTherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSONN Short Interest Over TimeSONN Days to Cover Over TimeSONN Percentage of Float Shorted Over Time Sonnet BioTherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20251,030,000 shares $3.42 million -9.7%18.0%0.3 $3.32 7/15/20251,140,000 shares $11.14 million +2,667.0%18.4%0.3 $9.77 6/30/202541,200 shares $51.09 thousand -32.2%1.3%0 $1.24 6/15/202560,800 shares $69.92 thousand +26.9%1.9%1.4 $1.15 5/31/202547,900 shares $56.28 thousand -51.2%1.5%1.2 $1.18 5/15/202598,100 shares $120.66 thousand -21.1%3.1%2.3 $1.23 4/30/2025124,300 shares $177.75 thousand -24.4%4.1%2.5 $1.43 4/15/2025164,400 shares $210.43 thousand +44.5%5.4%2.5 $1.28 3/31/2025113,800 shares $152.49 thousand +121.0%3.8%0.9 $1.34 3/15/202551,500 shares $70.29 thousand -44.5%1.7%0.3 $1.36 Get the Latest News and Ratings for SONN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sonnet BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/202592,800 shares $143.84 thousand +16.4%3.1%0.1 $1.55 2/15/202579,700 shares $126.72 thousand -31.1%2.6%0.1 $1.59 1/31/2025115,600 shares $190.74 thousand +82.3%3.8%0.1 $1.65 1/15/202563,400 shares $96.37 thousand +1.4%2.1%0 $1.52 12/31/202462,500 shares $91.25 thousand -71.3%2.2%0 $1.46 12/15/2024218,100 shares $394.76 thousand +443.9%7.6%0.2 $1.81 11/30/202440,100 shares $103.06 thousand +13.9%5.1%0 $2.57 11/15/202435,200 shares $106.30 thousand -46.8%4.4%0.1 $3.02 10/31/202466,200 shares $299.89 thousand +218.3%3.9%0.2 $4.53 10/15/202420,800 shares $100.67 thousand +61.2%3.4%0.8 $4.84 9/30/202412,900 shares $86.56 thousand -62.8%2.0%0.5 $6.71 9/15/202434,700 shares $28.12 thousand -21.9%0.7%0.3 $0.81 8/31/202444,400 shares $32.01 thousand -32.4%0.9%0.3 $0.72 8/15/202465,700 shares $53.22 thousand +53.2%1.3%0.5 $0.81 7/31/202442,900 shares $33.68 thousand +168.1%0.9%0.8 $0.79 7/15/202416,000 shares $14.12 thousand -49.4%0.3%0.3 $0.88 6/30/202431,600 shares $29.63 thousand -90.7%1.1%0.9 $0.94 6/15/2024338,600 shares $558.69 thousand -1.7%12.0%9.6 $1.65 5/31/2024344,300 shares $540.55 thousand -15.7%12.2%4.1 $1.57 5/15/2024408,400 shares $722.87 thousand +2.1%14.5%4.2 $1.77 4/30/2024400,200 shares $708.35 thousand -5.7%14.4%4 $1.77 4/15/2024424,200 shares $767.80 thousand -6.2%15.3%4.3 $1.81 3/31/2024452,200 shares $841.09 thousand -18.9%16.3%4.5 $1.86 3/15/2024557,500 shares $1.13 million +119.4%20.1%5.1 $2.02 2/29/2024254,100 shares $500.58 thousand +9.5%9.1%2.5 $1.97 2/15/2024232,100 shares $378.32 thousand +38.8%8.4%4.7 $1.63 1/31/2024167,200 shares $244.11 thousand +2.0%6.0%3 $1.46 1/15/2024163,900 shares $219.63 thousand +44.5%5.9%2.2 $1.34 12/31/2023113,400 shares $197.32 thousand +21.2%4.1%1.5 $1.74 12/15/202393,600 shares $131.98 thousand +49.5%3.4%1.3 $1.41Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad)On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.Click here to download the guide and protect your assets before Sept 15th. 11/30/202362,600 shares $87.01 thousand +18.1%2.4%0.9 $1.39 11/15/202353,000 shares $68.90 thousand -11.5%2.0%0.7 $1.30 10/31/202359,900 shares $74.28 thousand +24.5%2.5%0.7 $1.24 10/15/202348,100 shares $111.59 thousand -9.3%3.3%0.7 $2.32 9/30/202353,000 shares $151.85 thousand +59.6%3.7%0.7 $2.87 9/15/202333,200 shares $119.52 thousand -1.2%2.3%0.4 $3.60 8/31/202333,600 shares $147.84 thousand -94.1%2.3%0.3 $4.40 8/15/2023570,500 shares $186.61 thousand +59.9%N/A0.1 $0.33 7/31/2023356,700 shares $118.64 thousand -39.4%N/A0.1 $0.33 7/15/2023588,400 shares $255.31 thousand -19.4%N/A0.1 $0.43 6/30/2023729,900 shares $357.65 thousand -64.2%N/A0.2 $0.49 6/15/20232,040,000 shares $1.90 million -24.2%13.6%0.5 $0.93 5/31/20232,690,000 shares $1.38 million +441.9%15.7%0.9 $0.51 5/15/2023496,400 shares $111.04 thousand -46.1%2.8%0.3 $0.22 4/30/2023921,700 shares $220.75 thousand +255.7%5.0%0.9 $0.24 4/15/2023259,100 shares $94.57 thousand +115.4%1.3%0.3 $0.37 3/31/2023120,300 shares $43.31 thousand -45.2%0.6%0.2 $0.36 3/15/2023219,500 shares $122.96 thousand -41.0%1.1%0.4 $0.56 2/28/2023372,200 shares $314.40 thousand -30.7%1.9%0.8 $0.84 2/15/2023536,700 shares $520.55 thousand +197.5%2.8%1.1 $0.97 1/31/2023180,400 shares $207.46 thousand -46.7%2.4%0.2 $1.15 1/15/2023338,700 shares $477.57 thousand +154.7%4.5%0.1 $1.41 12/30/2022133,000 shares $152.95 thousand +830.1%1.8%0 $1.15 12/15/202214,300 shares $13.87 thousand -96.0%0.2%0 $0.97 11/30/2022359,900 shares $359.90 thousand +11.7%8.7%0.1 $1.00 11/15/2022322,300 shares $393.21 thousand +125.4%7.8%0.1 $1.22 10/31/2022143,000 shares $275.99 thousand -15.8%3.5%0 $1.93 10/15/2022169,800 shares $212.25 thousand -74.0%4.1%0.5 $1.25 9/30/2022652,200 shares $958.73 thousand +1,427.4%15.7%1.9 $1.47 9/15/202242,700 shares $135.70 thousand -88.3%1.0%0.1 $3.18 8/31/2022363,800 shares $76.83 thousand +52.7%N/A0.3 $0.21 8/15/2022238,300 shares $69.25 thousand +181.4%N/A0.2 $0.29 7/31/202284,700 shares $23.23 thousand -68.2%N/A0.1 $0.27 7/15/2022266,600 shares $78.99 thousand +5.8%N/A0.2 $0.30 6/30/2022252,100 shares $70.59 thousand -88.2%N/A0.1 $0.28 6/15/20222,130,000 shares $506.94 thousand +122.6%N/A0.9 $0.24 5/31/2022956,900 shares $251.66 thousand +10.5%N/A0.1 $0.26 5/15/2022866,100 shares $223.28 thousand -36.3%N/A0.1 $0.26 4/30/20221,360,000 shares $412.90 thousand -44.3%N/A0.2 $0.30 4/15/20222,440,000 shares $805.44 thousand -11.0%N/A0.4 $0.33 3/31/20222,740,000 shares $1.03 million +464.8%N/A0.4 $0.38 3/15/2022485,100 shares $133.79 thousand -40.5%N/A0.1 $0.28 2/28/2022814,800 shares $237.11 thousand -7.9%N/A0.7 $0.29 2/15/2022884,800 shares $272.52 thousand +275.6%N/A0.7 $0.31 1/31/2022235,600 shares $77.04 thousand -17.6%N/A0.2 $0.33 1/15/2022285,800 shares $100.03 thousand -17.0%N/A0.2 $0.35 12/31/2021344,500 shares $142.31 thousand -58.7%N/A0.2 $0.41 12/15/2021834,300 shares $420.07 thousand -26.2%N/A0.3 $0.50 11/30/20211,130,000 shares $642.74 thousand +3.7%N/A0.3 $0.57 11/15/20211,090,000 shares $660.54 thousand +123.0%N/A0.2 $0.61Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad)On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.Click here to download the guide and protect your assets before Sept 15th. 10/29/2021488,700 shares $313.45 thousand -17.8%N/A0 $0.64 10/15/2021594,200 shares $389.44 thousand +51.0%N/A0.1 $0.66 9/30/2021393,500 shares $238.46 thousand -92.3%N/A0 $0.61 9/15/20215,120,000 shares $3.22 million +5.4%N/A0.5 $0.63 8/31/20214,860,000 shares $3.35 million +46.0%N/A0.6 $0.69 8/13/20213,330,000 shares $3.25 million +2.8%N/A0.7 $0.98 7/30/20213,240,000 shares $3.43 million +53.6%N/A3.6 $1.06 7/15/20212,110,000 shares $2.68 million +48.6%10.8%1.7 $1.27 6/30/20211,420,000 shares $2.24 million +86.4%7.3%1.2 $1.58 6/15/2021761,700 shares $1.16 million +44.8%3.9%0.7 $1.52 5/28/2021526,000 shares $815.30 thousand -39.0%2.7%0.5 $1.55 5/14/2021861,800 shares $1.26 million +194.1%4.5%0.7 $1.46 4/30/2021293,000 shares $588.93 thousand -12.8%1.8%0.2 $2.01 4/15/2021336,000 shares $705.60 thousand -12.5%2.1%0.3 $2.10 3/31/2021383,900 shares $796.59 thousand -54.5%2.4%0.4 $2.08 3/15/2021843,100 shares $2.10 million +44.4%5.3%0.8 $2.49 2/26/2021583,800 shares $1.38 million -20.2%3.7%0.5 $2.37 2/12/2021731,500 shares $2.21 million -14.7%4.7%0.7 $3.02 1/29/2021857,900 shares $2.31 million -3.2%5.6%0.9 $2.69 1/15/2021886,200 shares $2.20 million No Change5.8%1.1 $2.48 SONN Short Interest - Frequently Asked Questions What is Sonnet BioTherapeutics' current short interest? Short interest is the volume of Sonnet BioTherapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 1,030,000 shares of SONN short. 18.04% of Sonnet BioTherapeutics' shares are currently sold short. Learn More on Sonnet BioTherapeutics' current short interest. What is a good short interest percentage for Sonnet BioTherapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.04% of Sonnet BioTherapeutics' floating shares are currently sold short. Is Sonnet BioTherapeutics' short interest increasing or decreasing? Sonnet BioTherapeutics saw a decline in short interest in July. As of July 31st, there was short interest totaling 1,030,000 shares, a decline of 9.6% from the previous total of 1,140,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sonnet BioTherapeutics' float size? Sonnet BioTherapeutics currently has issued a total of 6,750,000 shares. Some of Sonnet BioTherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sonnet BioTherapeutics currently has a public float of 5,710,000 shares. How does Sonnet BioTherapeutics' short interest compare to its competitors? 18.04% of Sonnet BioTherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sonnet BioTherapeutics: Clene Inc. (3.90%), Renovaro Inc. (0.70%), Exicure, Inc. (2.97%), Sol-Gel Technologies Ltd. (2.32%), PepGen, Inc. (4.49%), Senti Biosciences, Inc. (3.49%), Hyperion DeFi, Inc. (4.05%), Eagle Pharmaceuticals, Inc. (0.46%), CalciMedica Inc. (0.78%), LAVA Therapeutics N.V. (0.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Sonnet BioTherapeutics stock? Short selling SONN is an investing strategy that aims to generate trading profit from Sonnet BioTherapeutics as its price is falling. SONN shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sonnet BioTherapeutics? A short squeeze for Sonnet BioTherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SONN, which in turn drives the price of the stock up even further. How often is Sonnet BioTherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SONN, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Clene Short Squeeze Renovaro Short Squeeze Exicure Short Squeeze Sol-Gel Technologies Short Squeeze PepGen Short Squeeze Senti Biosciences Short Squeeze Hyperion DeFi Short Squeeze Eagle Pharmaceuticals Short Squeeze CalciMedica Short Squeeze LAVA Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SONN) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonnet BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access